Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Interestingly, children born to mothers who received 1000 IU vitamin D daily beginning at 14 weeks' gestation demonstrated lower odds of AD at 1 year of age compared to control (p = 0.04).

Source: Dietary Supplements. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Clinical trials on the primary prevention of AD were included in this review while observational studies, animal studies, laboratory studies, systematic reviews, meta‐analyses, and case reports were excluded.

Source: Methods.

The State of Prevention of Atopic Dermatitis: An Updated Review

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The State of Prevention of Atopic Dermatitis: An Updated Review

Review / evidence synthesis · Pediatric Dermatology · 2026

Original publication title

The State of Prevention of Atopic Dermatitis: An Updated Review

Alexandra Kiszluk; Peter Lio

© 2026 The Author(s). Pediatric Dermatology published by Wiley Periodicals LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

Atopic dermatitis (AD) is a chronic inflammatory skin disorder that has a high worldwide prevalence and carries substantial psychosocial and financial burden. As such, the prevention of AD is an important area of research. In this review, we provide an update synthesizing relevant clinical trials published from January 2020 through July 2025. Based on the available evidence, moisturizers and probiotics in infancy appear to have the most benefit in the primary prevention of AD compared to other interventions. However, relatively small effects, varying results, and heterogeneity of trial design make firm conclusions impossible at this time.

Authors’ abstract

ABSTRACT

Atopic dermatitis (AD) is a chronic inflammatory skin disorder that has a high worldwide prevalence and carries substantial psychosocial and financial burden. As such, the prevention of AD is an important area of research. In this review, we provide an update synthesizing relevant clinical trials published from January 2020 through July 2025. Based on the available evidence, moisturizers and probiotics in infancy appear to have the most benefit in the primary prevention of AD compared to other interventions. However, relatively small effects, varying results, and heterogeneity of trial design make firm conclusions impossible at this time.

Publication and source details

Original title: The State of Prevention of Atopic Dermatitis: An Updated Review

Alexandra Kiszluk; Peter Lio

Pediatric Dermatology · 2026

* Correspondence:
Alexandra Kiszluk (a.kiszluk@mail.com)
© 2026 The Author(s). Pediatric Dermatology published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:57:44.377533+00:00

DOI: 10.1111/pde.70157 · PMC13206429